Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Burkitt Lymphoma 14Vomiting 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Nausea 5Leukemia 5Recurrence 4Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Breast Neoplasms 3Blast Crisis 3Smoldering Multiple Myeloma 2Sarcoma 2Prostatic Neoplasms 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmacytoma 2Ovarian Neoplasms 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2

Interventions

Dexamethasone 9Calcium Dobesilate 7Bortezomib 5Melphalan 4Cyclophosphamide 3ixazomib 2Thalidomide 2Doxycycline 2dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1birtamimab 1auricularum 1Tacrolimus 1Lenalidomide 1Etoposide 1Doxorubicin 1Cisplatin 1Bendamustine Hydrochloride 1Antilymphocyte Serum 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Amyloidosis × dexamethasone acetate × Clear all
NCT01864018 2025-07-24

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

Mayo Clinic

Phase 1/2 Completed
87 enrolled 13 charts
Plasma cell

Amyloidosis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡